·博士：2010年9月-2018年6月，西安交通大学侯宗濂医学实验班（八年制），肿瘤学。

 

·2020年1月-至今，浙江省人民医院，主治医师；
·2018年9月-2019年12月，浙江省人民医院，住院医师。

 

1.Rho 通过调控 MYH9 介导乳腺癌侵袭转移的机制研究，国家自然科学基金青年科学基金项目，2019年-2021年。

 

1.Chen K, Zhou Y, Jin W, Zhu Q, Lu C,Niu N, Wang Y, Mou Y, Chen Z. Laparoscopic pancreaticoduodenectomy versus open pancreaticoduo- denectomy for pancreatic ductal adenocarcinom: Oncologic outcomes and long-term survival. Surgical Endoscopy, 2019.
2.Xiao Wang, Dan Su, Zhiquan Qin, Zheling Chen. Identification of FOXN4 as a tumor suppressor of breast carcinogenesis via the activation of TP53 and deactivation of Notch signaling. Gene. Available online 17 August 2019
3.Chen K, Quan J , Yang J, Chen Z .The potential markers of endocrine resistance amongHR+?/HER2+?breast cancer patients.Clin Transl Oncol. 2019 Jun 17. doi: 10.1007/s12094-019-02163-2
4.Yang J , Zhang X , Chen Z , Shen Y , Wang F , Wang Y , Liu Y , Liu P , Yang J .Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer.Cell Death Dis. 2019 Feb 21;10(3):179.
5.Chen ZL, Yang J, Shen YW, Li ST, Wang X, Lv M, Wang BY, Li P, Zhao W, Qiu RY, Liu Y, Liu PJ, Yang J. AmotP130 regulates Rho GTPase and decreases breast cancer cell mobility [J]. Journal of Cellular and Molecular Medicine, 2018, 22(4):2390-2403.
6.Chen ZL , Zhao A , Li P , Zhang M , Yang J , Zhang L , Zhao X , Yang J , Wang L.Clinical use of trastuzumab combined with different chemotherapy regimensin multi-line treatment of advanced human epidermal growth factor receptor2-positive gastric cancer: A case report. Oncol Lett. 2018 Oct;16(4):4614-4620.
7.Chen ZL, Yang J, Li ST, Lv M, Shen YW, Wang BY, Li P, Yi M, Zhao XA, Zhang LX, Wang L, Yang J. Invasive lobular carcinoma of the breast: a special histological type compared with invasive ductal carcinoma [J]. PLoS One, 2017, 12(9): e0182397.
8.Chen ZL, Ren YH, Du XL, Yang J, Shen YW, Li ST, Wu YY, Lv M, Dong DF, Li EX, Li W, Liu PJ, Yang J, Yi M. Incidence and survival differences in esophageal cancer among ethnic groups in the United States [J]. Oncotarget, 2017, 8(29): 47037–47051.
9.Chen ZL, Shen YW, Li ST, Li CL, Zhang LX, Yang J, Lv M, Lin YY, Wang X, Yang J. The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis [J]. OncoTargets and Therapy, 2016, 9:3233-3247.
10.Ke Chen, Zheling Chen, Weiwei Jin, Qicong Zhu, Chao Lu, Yuanyu Wang, Yucheng Zhou, Yiping Mou. EUS- versus ERCP-guided biliary drainage for malignant biliary obstruction: evidence from randomized controlled studies. Annals of pancreatic cance.